Holen Sie sich die Stockscreener-App
113.02
0.45%
-0.51
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$113.53
Offen:
$112.35
24-Stunden-Volumen:
3.64M
Relative Volume:
2.72
Marktkapitalisierung:
$12.61B
Einnahmen:
$2.90B
Nettoeinkommen (Verlust:
$239.11M
KGV:
53.57
EPS:
2.1097
Netto-Cashflow:
$492.62M
1W Leistung:
+13.02%
1M Leistung:
+16.72%
6M Leistung:
+16.82%
1J Leistung:
+14.40%
1-Tages-Spanne:
$111.57
$116.16
1-Wochen-Bereich:
$97.39
$116.16
52-Wochen-Spanne:
$81.22
$118.30
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
113.02 | 12.67B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
Revvity opens the weekend with strategy focus, shares on NYSE radar - Ad-hoc-news.de
Enterprise value to revenue forward of Revvity, Inc. – NYSE:RVTY - TradingView
Price to sales forward of Revvity, Inc. – NYSE:RVTY - TradingView
Price to earnings forward of Revvity, Inc. – NYSE:RVTY - TradingView
RVTY Reinstated by Bernstein -- Market Perform Rating Announced - GuruFocus
Bernstein Maintains Revvity(RVTY.US) With Hold Rating, Maintains Target Price $115 - Moomoo
Bernstein SocGen resumes Revvity stock coverage with Market Perform - Investing.com UK
Revvity Inc. stock outperforms competitors on strong trading day - MSN
Revvity, Inc. Actuals & Estimates (NYSE:RVTY) - TradingView
Bernstein SocGen resumes Revvity stock coverage with Market Perform By Investing.com - Investing.com Canada
Revvity (RVTY) Coverage Initiated by Bernstein with $115 Target - GuruFocus
Revvity launches Signals AI to advance scientific R&D workflows - MSN
PKN Forecast — Price Target — Prediction for 2027 - TradingView
Revvity, Inc. Actuals & Estimates (DUS:PKN) - TradingView
Revvity plans second quarter earnings release, shares on NASDAQ in a crowded diagnostics peer group - Ad-hoc-news.de
RVTY Forecast — Price Target — Prediction for 2027 - TradingView
Revvity Inc (RVTY) Shares Surge 7.5% -- What GF Score of 75 Tells Investors - GuruFocus
Revvity, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.0357143 Sh - TradingView
Revvity Rises as Investors Weigh New AI Launch and Earlier Q1 Strength - Quiver Quantitative
Revvity Jumps 6.8% Amid Sector-Wide Rally - AlphaStreet
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Revvity’s New Signals AI-Powered R&D Platform (RVTY) Has Changed Its Investment Story - simplywall.st
Barclays Maintains Revvity(RVTY.US) With Hold Rating, Maintains Target Price $105 - Moomoo
Revvity edges higher with a clear analyst consensus, shares backed by Buy ratings - Ad-hoc-news.de
Revvity Launches Signals AI to Advance Scientific R&D Workflows - Zacks Investment Research
Revvity Enhances AI Features in Signals Software (RVTY) - GuruFocus
Revvity focuses on biologics software strategy, shares trade quietly on the NYSE - Ad-hoc-news.de
Revvity Expands Signals One Platform With New AI Capabilities for Scientific R&D - citybiz
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D - Yahoo Finance
Revvity Inc (RVTY) Institutional Confidence - TradingKey
Revvity Inc. Stockbackground snapshot on diagnostics and life science tools - Ad-hoc-news.de
Revvity StockWeekly review and sector context - AD HOC NEWS
Is Revvity Stock Underperforming the Nasdaq? - Barchart
Why Revvity’s Signals Image Artist software is becoming a quiet lab workhorse - AD HOC NEWS
Revvity Inc (RVTY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Revvity Inc (RVTY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Revvity Inc (RVTY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Revvity Inc (RVTY) Stock Down 3.4% -- Now Undervalued? GF Score: 78/100 - GuruFocus
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity Inc (RVTY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Revvity Inc (RVTY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Revvity (RVTY) VP Anita Gonzales surrenders shares for RSU tax withholding - Stock Titan
Revvity Inc (RVTY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Revvity Inc (RVTY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Revvity Inc (RVTY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Trading the Move, Not the Narrative: (RVTY) Edition - Stock Traders Daily
Revvity (NYSE:RVTY) Gains Market Attention as Technical Strength Builds - Kalkine Media
What to expect from Revvity's next quarterly earnings report - MSN
Revvity Inc (NYSE:RVTY) Shows Technical Breakout Setup with Perfect Score - ChartMill
Alithea Genomics, Revvity partner to expand global access to Transcriptomics for drug discovery - Indian Pharma Post
Revvity Inc. Stock (US76155R1086): Analyst Views and Valuation Put Healthcare Name in Focus - AD HOC NEWS
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):